Haemonetics Corporation News Releasehttp://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-news&nyo=0A Collection of Haemonetics Corporation News Releaseen-usUncategorizedThu, 23 May 2013 20:46:18 GMTHaemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conferencehttp://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1823965Uncategorized1823965_NEWSThu, 23 May 2013 20:40:24 GMTHaemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidancehttp://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1813469Uncategorized1813469_NEWSWed, 01 May 2013 11:00:00 GMTHaemonetics Completes Hemerus Medical, LLC Acquisitionhttp://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1813446Uncategorized1813446_NEWSWed, 01 May 2013 10:59:54 GMTHaemonetics Sets Date for Investor/Analyst Meetinghttp://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1810363Uncategorized1810363_NEWSWed, 24 Apr 2013 12:00:31 GMTHaemonetics Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013http://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1802094Uncategorized1802094_NEWSMon, 01 Apr 2013 20:00:46 GMTHaemonetics to Present at The Raymond James Institutional Investors Conferencehttp://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1788619Uncategorized1788619_NEWSMon, 25 Feb 2013 13:01:14 GMTHaemonetics' CMO, Mark Popovsky, Joins U.S. Health and Human Services Advisory Committee on Blood Safetyhttp://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1785132Uncategorized1785132_NEWSThu, 14 Feb 2013 13:00:24 GMTHaemonetics to Present at Citi 2013 Global Healthcare Conferencehttp://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1784586Uncategorized1784586_NEWSWed, 13 Feb 2013 13:01:21 GMTHaemonetics to Present at Leerink Swann 2013 Global Healthcare Conferencehttp://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1782355Uncategorized1782355_NEWSWed, 06 Feb 2013 21:01:09 GMTHaemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70http://phx.corporate-ir.net/phoenix.zhtml?c=72118&p=RssLanding&cat=news&id=1779215Uncategorized1779215_NEWSWed, 30 Jan 2013 11:01:17 GMT